Fraunhofer Institute for Cell Therapy and Immunology IZI

United against Corona

Fraunhofer vs. Corona

Fraunhofer experts are supporting the efforts of industry and society to cope with the immediate effects and the consequences to come of the COVID-19 pandemic. Fraunhofer IZI is involved with the following projects.

More info

C19 lung chip

Drug repurposing using a COVID-19 infection model in an immunocompetent lung-on-chip platform

more info

DEFEND-CoV2

Testing of vaccines and active agents against SARS-CoV-2

more info

CoroVacc

Development of a Sars-CoV-2-specific vaccine based on Herpes viruses

more info

CoronaSense

Covid-19 peptide binding analysis for diagnostics and treatment

more info

CoV-tot

Examination of the influence of virus inactivation on the epitope spectrum in (COVID-19) serums

more info

VirenWolf

Virucidal tungsten carbide-based component surfaces for intensive medical and nursing care facilities

More info

disCoVer 21

Highly sensitive lateral flow systems for the detection of viral pathogens

more info

Full force against the pandemic and its consequences

The German Federal Ministry of Education and Research (BMBF) has provided funds for research on coronavirus and for the development of drugs and vaccines.

CoVER-Ab

Human antibodies against SARS-CoV2 for COVID-19 prevention and treatment

more info

SENSE-CoV2

Analysis of the innate immune recognition of SARS-CoV-2 using recombinant viruses

More info

EpiCoV2020

SARS-CoV-2 specific serological diagnostics based on epitopes

More info

Research funding from the German Free State of Saxony

The Saxon State Ministry of Science, Culture and Tourism (SMWK) provides short-term funding for research on SARS-CoV2.

Covidval

Clinical study regarding the use of ACE inhibitors as a treatment option in the fight against COVID-19

more info